Seres Therapeutics MCRB
NASDAQ MCRB
$2.30 -0.01 (-0.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) EV to CFO (2016 - 2025)

Updated

Seres Therapeutics' (MCRB) EV to CFO stood at 86.33 in Q4 2025.

Analysis

Seres Therapeutics (MCRB) EV to CFO (2016 - 2025) Analysis & Trends

Starting with Q1 2016, Seres Therapeutics' EV to CFO history includes 7 quarters.

  • Across earlier years, EV to CFO came in at 70.98 in FY2021.
  • The Q4 2025 figure is the lowest quarterly EV to CFO since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Seres Therapeutics 22.42 Mn -116.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 86.33
Dec 31, 2021 70.98
Sep 30, 2021 7.18
Dec 31, 2016 3.86
Sep 30, 2016 5.50
Jun 30, 2016 17.77
Mar 31, 2016 10.71
API Access

Seres Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MCRB&period=max&api_key=YOUR_API_KEY